Welcoming Sano
By Phil Black, June 29, 2015
True portfolio company Sano announced their funding last week, and I am very excited to publicly welcome the company and Founder Ashwin Pushpala to True.
Working privately for nearly three years, Sano has developed a breakthrough biometric sensor that will help people understand what’s happening inside their bodies through continuously monitoring important markers in their bodies’ chemistry, starting with blood glucose levels. This data will be presented in ways that will help people get meaningful insights into how their body is functioning.
It has been a joy to work with the Sano team as they iterated and developed their first product these last three years. Prior to founding Sano, Ashwin was part of the founding team at SinuSys, a medical device company dedicated to producing novel therapeutic treatments for chronic sinusitis. Here at Sano, he has brought together the best minds in biochemistry, data science, hardware, software and semiconductor manufacturing from leading technology companies and academic institutions to create and build a sensor that will measure (and eventually predict) metabolic activity.
As investors, we’re incredibly excited about the intersection of health, wearables and scientific discovery within the human body and we are thrilled to be partnering with Sano.
Ashwin and team Sano: Welcome to True!